The Venetoclax Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient With COVID : VEN AZA Effectively Targets AML Clones. Mediterr J Hematol Infect Dis 2022, 14 (1), e2022041. https://doi.org/10.4084/MJHID.2022.041.